Document Detail


Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism.
MedLine Citation:
PMID:  18654047     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Free radicals are known to activate coagulation and inhibit fibrinolysis. Edaravone, a free radical scavenger, protects vascular endothelial cells and neurons during acute brain ischemia in in vitro models. Hemorrhagic transformation and treatment outcomes were retrospectively examined in 76 patients with acute cardiogenic embolism treated with edaravone in addition to routine treatment within 24 hours of the onset of symptoms. Hemorrhagic transformation was categorized according to European Cooperative Acute Stroke Study-II. Patient characteristics were also evaluated, including evidence of hypertension, diabetes mellitus, hyperlipidemia, coronary heart disease, history of smoking, National Institutes of Health Stroke Scale on arrival, and modified Rankin scale at 3 months post-onset. Edaravone administration was one of the factors that contributed to increased frequency of hemorrhagic transformation, but had showed no significant relationship with the outcome. The present study showed that edaravone administration increased the frequency of hemorrhagic transformation with heparin in patients with cardiogenic embolism. Free radical scavenging may have promoted the coagulating conditions. Edaravone administration may allow reduction of the dose of heparin and tissue plasminogen activator in patients with acute ischemic stroke.
Authors:
Masahiro Mishina; Yuichi Komaba; Shiro Kobayashi; Shushi Kominami; Takaharu Fukuchi; Takayuki Mizunari; Akira Teramoto; Yasuo Katayama
Related Documents :
17478737 - Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for t...
9158637 - Implementation of a stroke code system in mobile, alabama. diagnostic and therapeutic y...
12574567 - Measuring longitudinally the metabolic demands of stroke patients: resting energy expen...
15887057 - Can a subgroup of ocd patients with motor abnormalities and poor therapeutic response b...
20926147 - Left ventricular function and energy homeostasis in patients with type 1 diabetes with ...
21557237 - What faces reveal: impaired affect display in facial paralysis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurologia medico-chirurgica     Volume:  48     ISSN:  1349-8029     ISO Abbreviation:  Neurol. Med. Chir. (Tokyo)     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-07-25     Completed Date:  2009-02-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400775     Medline TA:  Neurol Med Chir (Tokyo)     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  292-7     Citation Subset:  IM    
Affiliation:
Neurological Institute, Nippon Medical School Chiba-Hokusoh Hospital, Chiba, Japan. mishina@nms.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Antipyrine / administration & dosage,  adverse effects,  analogs & derivatives*
Cerebral Hemorrhage / chemically induced*,  diagnosis
Dose-Response Relationship, Drug
Female
Free Radical Scavengers / administration & dosage,  adverse effects*
Heart Diseases / complications*,  drug therapy
Humans
Infusions, Intravenous
Intracranial Embolism / drug therapy*
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Thrombosis / complications*,  drug therapy
Treatment Outcome
Chemical
Reg. No./Substance:
0/Free Radical Scavengers; 60-80-0/Antipyrine; 89-25-8/phenylmethylpyrazolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experimental petit mal-like seizure induced by microinjection of kainic acid into the unilateral med...
Next Document:  Lumbar synovial cysts: experience with nine cases.